$CAPR
CAPRICOR THERAPEUTICS, INC.

2015 Q1 Form 10-Q Financial Statement

#000114420415029906 Filed on May 13, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $1.788M $1.042M
YoY Change 71.64% 346.51%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.400M $850.0K
YoY Change 64.71% 80.85%
% of Gross Profit
Research & Development $3.807M $1.375M
YoY Change 176.93% 15.41%
% of Gross Profit
Depreciation & Amortization $24.80K $6.465K
YoY Change 283.63% 5.64%
% of Gross Profit
Operating Expenses $5.203M $2.227M
YoY Change 133.61% 33.71%
Operating Profit -$3.415M -$1.185M
YoY Change 188.06% -17.23%
Interest Expense $61.68K $25.33K
YoY Change 143.54% 582.48%
% of Operating Profit
Other Income/Expense, Net -$61.41K -$25.17K
YoY Change 143.93% -265.86%
Pretax Income -$3.480M -$1.210M
YoY Change 187.6% -14.79%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.476M -$1.211M
YoY Change 187.14% -14.57%
Net Earnings / Revenue -194.43% -116.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.336M -$1.034M
COMMON SHARES
Basic Shares Outstanding 16.22M shares 11.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.42M $13.31M
YoY Change 68.53% 4488.06%
Cash & Equivalents $6.939M $12.98M
Short-Term Investments $15.48M $326.2K
Other Short-Term Assets $2.250M $730.0K
YoY Change 208.22% 563.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.42M $14.03M
YoY Change 81.17% 3407.74%
LONG-TERM ASSETS
Property, Plant & Equipment $250.0K $163.5K
YoY Change 52.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.00K $50.00K
YoY Change 40.0% 400.0%
Total Long-Term Assets $2.050M $1.946M
YoY Change 5.34% 9628.8%
TOTAL ASSETS
Total Short-Term Assets $25.42M $14.03M
Total Long-Term Assets $2.050M $1.946M
Total Assets $27.47M $15.98M
YoY Change 71.94% 3703.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.380M $2.000M
YoY Change 69.0% 669.23%
Accrued Expenses $130.0K
YoY Change -35.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.545M $6.299M
YoY Change 19.78% 869.12%
LONG-TERM LIABILITIES
Long-Term Debt $9.160M $3.960M
YoY Change 131.31%
Other Long-Term Liabilities $3.450M $7.380M
YoY Change -53.25% 1700.0%
Total Long-Term Liabilities $12.60M $11.34M
YoY Change 11.12% 2665.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.545M $6.299M
Total Long-Term Liabilities $12.60M $11.34M
Total Liabilities $20.15M $17.64M
YoY Change 14.23% 1563.79%
SHAREHOLDERS EQUITY
Retained Earnings -$25.79M
YoY Change
Common Stock $33.12M $11.69K
YoY Change 283216.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.325M -$1.659M
YoY Change
Total Liabilities & Shareholders Equity $27.47M $15.98M
YoY Change 71.94% 3703.98%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$3.476M -$1.211M
YoY Change 187.14% -14.57%
Depreciation, Depletion And Amortization $24.80K $6.465K
YoY Change 283.63% 5.64%
Cash From Operating Activities -$2.050M $11.34M
YoY Change -118.08% -1061.02%
INVESTING ACTIVITIES
Capital Expenditures $27.46K $92.90K
YoY Change -70.45% 2854.87%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.257K
YoY Change -100.0% -99.5%
Cash From Investing Activities -$15.52M -$90.00K
YoY Change 17144.44% -120.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $16.45M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.48M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.050M 11.34M
Cash From Investing Activities -15.52M -90.00K
Cash From Financing Activities 16.48M 0.000
Net Change In Cash -1.090M 11.25M
YoY Change -109.69% 10127.27%
FREE CASH FLOW
Cash From Operating Activities -$2.050M $11.34M
Capital Expenditures $27.46K $92.90K
Free Cash Flow -$2.077M $11.25M
YoY Change -118.47% -1050.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11707051 shares
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 0.25in; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
360233 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
202984 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
235523 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
25420259 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
11607545 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6939220 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8034765 USD
CY2015Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15483890 USD
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 USD
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2047930 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2977024 USD
CY2015Q1 us-gaap Grants Receivable Current
GrantsReceivableCurrent
746235 USD
CY2015Q1 us-gaap Other Assets
OtherAssets
69455 USD
CY2014Q4 us-gaap Other Assets
OtherAssets
55320 USD
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2745935 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1699254 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4166667 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4166667 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7545301 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6299633 USD
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3124999 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4166666 USD
CY2015Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
9155857 USD
CY2014Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
9155857 USD
CY2015Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
320346 USD
CY2014Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
258639 USD
CY2015Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12601202 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13581162 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
16222 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
11707 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33103520 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16054697 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3940 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25791258 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22315127 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
7324544 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-6248723 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27471047 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13632072 USD
CY2015Q1 us-gaap Marketable Securities
MarketableSecurities
15483890 USD
CY2015Q1 capr Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
22400000 USD
CY2014Q4 capr Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
8000000 USD
CY2014Q1 capr Proceeds From Development Fee
ProceedsFromDevelopmentFee
12500000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5041281 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6098330 shares
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
576 USD
CY2015Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
30000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16221985 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16221985 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
303881 shares
CY2015Q1 capr Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
CY2015Q1 capr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
15401 shares
CY2015Q1 capr Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
288480 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.02
CY2015Q1 capr Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0
CY2015Q1 capr Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
2.27
CY2015Q1 capr Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.43
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.17 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82 pure
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022 pure
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
84544 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
563533 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4500000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y10M24D
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.65
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.23
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62118 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49930 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11707051 shares
CY2015Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
26000000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
371076 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
364866 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
96750 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
832692 USD
CY2015Q1 capr Leases Monthly Payments For First Twelve Months
LeasesMonthlyPaymentsForFirstTwelveMonths
16620 USD
CY2015Q1 capr Leases Monthly Payments For Second Twelve Months
LeasesMonthlyPaymentsForSecondTwelveMonths
17285 USD
CY2013Q4 capr Additional Milestone Payments To Be Received Contingent Upon Exercise Of Options
AdditionalMilestonePaymentsToBeReceivedContingentUponExerciseOfOptions
325000000 USD
CY2015Q1 us-gaap Payments For Royalties
PaymentsForRoyalties
20000 EUR
CY2014Q1 capr Collaboration Revenue
CollaborationRevenue
1041667 USD
CY2015Q1 capr Collaboration Revenue
CollaborationRevenue
1041667 USD
CY2014Q1 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2015Q1 us-gaap Revenue From Grants
RevenueFromGrants
746235 USD
CY2014Q1 us-gaap Revenues
Revenues
1041667 USD
CY2015Q1 us-gaap Revenues
Revenues
1787902 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1374757 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3807087 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
852347 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1395540 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2227104 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
5202627 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1185437 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3414725 USD
CY2014Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
153 USD
CY2015Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
275 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
25327 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
61681 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25174 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1210035 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3480071 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11689441 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14869746 shares
CY2015Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
572121 USD
CY2015Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34999 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24802 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61406 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3476131 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-846627 USD
CY2015Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-929094 USD
CY2014Q1 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
0 USD
CY2015Q1 capr Increase Decrease From Grants Receivable
IncreaseDecreaseFromGrantsReceivable
386002 USD
CY2014Q1 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
-52614 USD
CY2015Q1 capr Increase Decrease In Prepaid And Other Current Assets
IncreaseDecreaseInPrepaidAndOtherCurrentAssets
-32539 USD
CY2014Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
0 USD
CY2015Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
14135 USD
CY2014Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
22049 USD
CY2015Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1046681 USD
CY2014Q1 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
57646 USD
CY2015Q1 capr Increase Decrease In Accounts Payable And Accrued Expenses Related Party
IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty
198987 USD
CY2014Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
25327 USD
CY2015Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
61707 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11458333 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1041667 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
11342994 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2052004 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92901 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27455 USD
CY2014Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
0 USD
CY2015Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
9473 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-94314 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15524758 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16446218 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
933 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
34999 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
933 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16481217 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11249613 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1095545 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1729537 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12979150 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2014Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2015Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2257 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2839045 shares
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1658822 shares
CY2015Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.523
CY2015Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.25
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000 USD
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7050000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2916 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12187 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
49000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
49000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
49000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
49000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
49000 USD
CY2015Q1 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
19581 USD
CY2014Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
14181 USD
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16446218 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
17957 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
21420 USD
CY2013Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50

Files In Submission

Name View Source Status
0001144204-15-029906-index-headers.html Edgar Link pending
0001144204-15-029906-index.html Edgar Link pending
0001144204-15-029906.txt Edgar Link pending
0001144204-15-029906-xbrl.zip Edgar Link pending
capr-20150331.xml Edgar Link completed
capr-20150331.xsd Edgar Link pending
capr-20150331_cal.xml Edgar Link unprocessable
capr-20150331_def.xml Edgar Link unprocessable
capr-20150331_lab.xml Edgar Link unprocessable
capr-20150331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v409342_10q.htm Edgar Link pending
v409342_ex31-1.htm Edgar Link pending
v409342_ex31-2.htm Edgar Link pending
v409342_ex32-1.htm Edgar Link pending
v409342_ex32-2.htm Edgar Link pending